Natural anti-mutagenic and anti-carcinogenic substances
Rahden-Staroń, I.
Postepy Biochemii 36(3-4): 16-22
1990
ISSN/ISBN: 0032-5422 PMID: 2095553 Document Number: 366275
Document emailed within 1 workday
Related Documents
Ceker, S.; Ogutcu, H.ıc.; Meral, S.; Agar, A.A.; Agar, G. 2019: Synthesis, anti-microbial and anti-mutagenic activities of some Schiff bases derivatives containing thiophene group Pakistan Journal of Pharmaceutical Sciences 32(6): 2679-2686Krivoshein, I.S.; Skuratovich, A.A.; Tyshkevich, L.V.; Rud'ko, A.P. 1984: Mutagenic and carcinogenic action of antimicrobial surface-active substances Antibiotiki 29(7): 519-527
Smilovici, W.; Abbal, M.; de Boissezon, J.F.; Ducos, J. 1972: Automatic determination of substances inhibiting anti-i and anti-i antibodies in various biological fluids Annales de l'Institut Pasteur 123(1): 118-119
Kano, S. 1999: Serological diagnosis of streptococcal infection (anti-streptolysin O; ASO, anti-streptokinase; ASK, anti-deoxyribonuclease B; ADNB, anti-hyaluronidase; AHD, anti-streptococcal polysaccharide; ASP) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 107-116
Kazimierska, E.; Górski, J. 1989: Anti-HBS, anti-CMV, and anti-HIV antibodies and HBS antigen in patients with hemophilia, malignant lymphomas, leukemias and multiple myeloma Acta Haematologica Polonica 20(2): 189-194
Zivković, V.; Stanković, A.; Cvetković, T.; Mitić, B.; Kostić, S.; Nedović, J.; Stamenković, B. 2014: Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus Srpski Arhiv Za Celokupno Lekarstvo 142(7-8): 431-436
Lebacq, A.M.; Goffinet, P.; De Bruyere, M.; Rodhain, J.; Sokal, G. 1982: Membrane marker studies with anti-T, anti-Ia (DR) and anti-myeloblast antisera in acute leukaemias European Journal of Cancer and Clinical Oncology 18(2): 147-153
Kumagai, T.; Kameko, M.; Kanai, M.; Maruyama, K. 1985: A study on autoantibodies including anti-nDNA, anti-RNP and anti-Sm antibody in various autoimmune diseases Rinsho Byori. Japanese Journal of Clinical Pathology 33(3): 293-297
Locht, H.; Pelck, R.; Manthorpe, R. 2008: Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome Journal of Rheumatology 35(5): 845-849
Devaux, C.; Pierres, M. 1982: Clonal analysis of B and T cell responses to Ia antigens. III. Characterization of 12 xenogeneic anti-idiotypic antisera to A.TH-derived anti-I-Ak and anti-I-Ek monoclonal antibodies Journal of Immunology 128(2): 751-757
Litvinov, N.N. 1985: Hygienic classification of carcinogenic substances and the potentials for its use in preventing carcinogenic exposures Gigiena i Sanitariia 1985(6): 10-13
Tanaka, M. 2005: RA-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, and anti-FRP antibodies) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 449-452
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Druckrey, H.; Preussmann, R.; Nashed, N.; Ivankovic, S. 1966: Carcinogenic alkylating substances. I. Dimethylsulfate, carcinogenic action in rats and probable cause of occupational cancer Zeitschrift für Krebsforschung 68(1): 103-111
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Birdsall, H.H.; Rossen, R.D. 1983: Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin Clinical and Experimental Immunology 53(2): 497-504
Nikolaeva, T.N.; Zorina, V.V.; Bondarenko, V.M. 2004: Immunostimulating and anti-carcinogenic activity of the normal intestinal lactoflora Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 39-43; 109
Williams, R.C.; Malone, C.C.; Silvestris, F.; Nickerson, K.G. 1997: Benign monoclonal gammopathy with IgG anti-DNA, anti-Sm and anti-F(ab')2 activity Clinical and Experimental Rheumatology 15(1): 33-38